Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Stirling

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|January 18, 1992
Antithrombin III and arterial diseaseT W Meade, J Cooper, G J Miller, et al.
British Journal of Haematology|August 1, 1976
Factor V in an industrial populationM Brozović, R Chakrabarti, Y Stirling, et al.
Thrombosis Research|April 1, 1995
Activation of factors XII and VII induced in citrated plasma in the presence of contact surfaceK A Mitropoulos, J C Martin, Y Stirling, et al.
Lancet (London, England)|September 15, 1984
Fibrinopeptide A and sudden coronary deathT W Meade, D J Howarth, Y Stirling, et al.
British Journal of Haematology|February 1, 1984
Management of planned pregnancy in a patient with congenital antithrombin III deficiencyD Samson, Y Stirling, L Woolf, et al.
Lancet (London, England)|January 1, 1983
Menopausal status and haemostatic variablesT W Meade, A P Haines, J D Imeson, et al.
Thrombosis Research|October 15, 1983
Haemostatic changes following surgeryC J Hawkey, Y Stirling, R Chakrabarti, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1994
Changes in clot deformability--a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarctionM C Scrutton, S B Ross-Murphy, G M Bennett, et al.
European Heart Journal|August 1, 1988
Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot studyT W Meade, H C Wilkes, Y Stirling, et al.
British Journal of Haematology|November 1, 1976
An epidemiological study of the haemostatic and other effects of oral contraceptivesT W Meade, M Brozović, R Chakrabarth, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|January 18, 1992
Antithrombin III and arterial diseaseT W Meade, J Cooper, G J Miller, et al.
British Journal of Haematology|August 1, 1976
Factor V in an industrial populationM Brozović, R Chakrabarti, Y Stirling, et al.
Thrombosis Research|April 1, 1995
Activation of factors XII and VII induced in citrated plasma in the presence of contact surfaceK A Mitropoulos, J C Martin, Y Stirling, et al.
Lancet (London, England)|September 15, 1984
Fibrinopeptide A and sudden coronary deathT W Meade, D J Howarth, Y Stirling, et al.
British Journal of Haematology|February 1, 1984
Management of planned pregnancy in a patient with congenital antithrombin III deficiencyD Samson, Y Stirling, L Woolf, et al.
Lancet (London, England)|January 1, 1983
Menopausal status and haemostatic variablesT W Meade, A P Haines, J D Imeson, et al.
Thrombosis Research|October 15, 1983
Haemostatic changes following surgeryC J Hawkey, Y Stirling, R Chakrabarti, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1994
Changes in clot deformability--a possible explanation for the epidemiological association between plasma fibrinogen concentration and myocardial infarctionM C Scrutton, S B Ross-Murphy, G M Bennett, et al.
European Heart Journal|August 1, 1988
Randomized controlled trial of low dose warfarin in the primary prevention of ischaemic heart disease in men at high risk: design and pilot studyT W Meade, H C Wilkes, Y Stirling, et al.
British Journal of Haematology|November 1, 1976
An epidemiological study of the haemostatic and other effects of oral contraceptivesT W Meade, M Brozović, R Chakrabarth, et al.
Pageof 8